Methyl 3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-2-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-4-oxoquinazoline-7-carboxylate
C37H29ClF6N8O6S — CID 154628937
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-2-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-4-oxoquinazoline-7-carboxylate
Methyl 3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-2-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-4-oxoquinazoline-7-carboxylate (PubChem CID 154628937) has the molecular formula C37H29ClF6N8O6S and a molecular weight of 863.20 g/mol. Its IUPAC name is methyl 3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-2-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-4-oxoquinazoline-7-carboxylate.
Molecular Properties
| Compound Name | Methyl 3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-2-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-4-oxoquinazoline-7-carboxylate |
|---|---|
| PubChem CID | 154628937 |
| Molecular Formula | C37H29ClF6N8O6S |
| Molecular Weight | 863.20 g/mol |
| Exact Mass | 862.15 |
| IUPAC Name | methyl 3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-2-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-4-oxoquinazoline-7-carboxylate |
| SMILES | COC(=O)c1ccc2c(=O)n(-c3ccc(Cl)c4c(NS(C)(=O)=O)nn(C)c34)c([C@H](Cc3cc(F)cc(F)c3)NC(=O)Cn3nc(C(F)F)c4c3C(F)(F)[C@@H]3C[C@H]43)nc2c1 |
| InChI | InChI=1S/C37H29ClF6N8O6S/c1-50-30-25(7-6-22(38)28(30)33(48-50)49-59(3,56)57)52-34(46-23-11-16(36(55)58-2)4-5-19(23)35(52)54)24(10-15-8-17(39)12-18(40)9-15)45-26(53)14-51-31-27(29(47-51)32(41)42)20-13-21(20)37(31,43)44/h4-9,11-12,20-21,24,32H,10,13-14H2,1-3H3,(H,45,53)(H,48,49)/t20-,21+,24-/m0/s1 |
| InChIKey | XXFQYTDFSIROAM-IMSXRSKXSA-N |
| XLogP | 5.81 |
| TPSA | 172.10 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 863.20 |
| LogP ≤ 5 | 5.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154628937 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.